The clinical research industry is taking notice.
Clinical Trial Vanguard‘s Jon Napitupulu recently covered our new partnership with Medidata, spotlighting how our integration is reshaping the way sites capture and transfer data. The piece breaks down what this means for sponsors, CROs, and the more than 2,500 research sites already using CRIO, including the potential to cut data entry time by roughly 90% and push source-to-EDC accuracy to near 100%.
From retiring manual double entry to accelerating database lock timelines, the article offers an in-depth look at how this partnership is positioning eSource as operational infrastructure, not just a nice-to-have.
Get the full analysis from Clinical Trial Vanguard, including what this means for site workflows, sponsor data strategies, and the broader competitive landscape. Click below to read the full article.